Coherus Oncology, Inc. - Common Stock, par value $0.0001 per share (CHRS)

CUSIP: 19249H103

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
120,781,538
Total 13F shares
62,082,313
Share change
-3,525,999
Total reported value
$50,064,190
Put/Call ratio
67%
Price per share
$0.81
Number of holders
114
Value change
-$6,457,989
Number of buys
49
Number of sells
49

Quarterly Holders Quick Answers

What is CUSIP 19249H103?
CUSIP 19249H103 identifies CHRS - Coherus Oncology, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Coherus Oncology, Inc. - Common Stock, par value $0.0001 per share (CHRS) as of Q1 2025

As of 31 Mar 2025, Coherus Oncology, Inc. - Common Stock, par value $0.0001 per share (CHRS) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 62,082,313 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., Rubric Capital Management LP, TANG CAPITAL MANAGEMENT LLC, Kohlberg Kravis Roberts & Co. L.P., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, CM Management, LLC, and C WorldWide Group Holding A/S. This page lists 114 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.